Literature DB >> 2943755

Relationship between plasma atrial natriuretic peptide levels and atrial pressure in man.

F Sato, K Kamoi, Y Wakiya, T Ozawa, O Arai, M Ishibashi, T Yamaji.   

Abstract

In an attempt to clarify the mechanisms regulating the release of atrial natriuretic peptide (ANP) in man, ANP levels in pulmonary arterial plasma determined by RIA were correlated to hemodynamic variables in 17 patients with heart disease who underwent cardiac catheterization and angiocardiography. In addition, plasma ANP levels in various blood vessels were determined in 7 patients with heart disease and in 7 normal subjects to determine the source and the site of removal of circulating ANP. A significantly positive correlation was found between plasma ANP levels and mean pulmonary arterial wedge pressure, while the correlation between plasma ANP levels and mean right atrial pressure was not significant. After the injection of contrast medium, both mean right arterial pressure and plasma ANP levels increased, and a significant positive correlation was found between the two variables. When ANP levels in plasma collected from various blood vessels were compared, the highest levels were found in the coronary sinus. Plasma ANP levels in the renal vein were the lowest and were 50% of the levels in the aorta. Plasma ANP levels in the superior vena cava and internal jugular vein were higher than that in the antecubital vein. Analysis of immunoreactive ANP in pooled plasma by high performance liquid chromatography revealed that the retention time of the main ANP peak coincided with that of synthetic human alpha ANP. These results indicate that circulating ANP mainly originates from the heart, the kidney rapidly takes up a significant amount of ANP from the circulation, and an increase in both left and right atrial pressure triggers ANP release in man.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2943755     DOI: 10.1210/jcem-63-4-823

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

Review 1.  The endocrinology and pathophysiology of alcoholic cirrhosis and functional renal failure--a review.

Authors:  E S Domurat; A N Elias
Journal:  J Natl Med Assoc       Date:  1992-02       Impact factor: 1.798

2.  Beta-adrenoceptor blockade potentiates exercise-induced release of atrial natriuretic peptide.

Authors:  G Deray; I Berlin; G Maistre; F Martinez; S Legrand; A Carayon; A Prost; A Puech; F Masson; J C Legrand
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  [Atrial natriuretic factor levels and pressure in the pulmonary circulation before and after coronary dilatation].

Authors:  K H Scholz; J Marten; C Herrmann; U Spaar; U Tebbe; K L Neuhaus; H Kreuzer
Journal:  Klin Wochenschr       Date:  1990-08-17

4.  Comparison of renal function under deliberate hypotension during epidural plus light-enflurane anesthesia and during enflurane anesthesia.

Authors:  Naoto Nagata; Mayumi Takasaki; Gohtaro Yoshikawa; Tadashi Agune; Michiyo Takeshita; Naoto Minamino
Journal:  J Anesth       Date:  1996-06       Impact factor: 2.078

5.  Atrial natriuretic peptide level and intracardiac pressure in cardiac transplant recipients.

Authors:  G Deray; G Maistre; M Desruenne; J Eurin; C Barthelemy; F Masson; A Baumelou; P Leger; C Cabrol; J C Legrand
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 6.  Molecular forms of natriuretic peptides in heart failure and their implications.

Authors:  Ye Olivia Xu-Cai; Qingyu Wu
Journal:  Heart       Date:  2009-05-17       Impact factor: 5.994

7.  Secretion of atrial natriuretic peptide from the heart in man.

Authors:  D R Singer; J W Dean; M G Buckley; G A Sagnella; G A MacGregor
Journal:  Br Heart J       Date:  1987-07

8.  Clearance of atrial natriuretic factor by lung, liver, and kidney in human subjects and the dog.

Authors:  A S Hollister; R J Rodeheffer; F J White; J R Potts; T Imada; T Inagami
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

9.  Changes in urinary kallikrein excretion and plasma natriuretic factor in a patient with primary aldosteronism with special reference to adrenal histology.

Authors:  S Hayami; T Nakada; H Kakizaki; T Yagisawa; H Kaneko; Y Iijima; H Obata; M Miura
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

Review 10.  Protection of kidney function and tissue integrity by pharmacologic use of natriuretic peptides and neprilysin inhibitors.

Authors:  Juan Brignone; Kasper Bostlund Assersen; Mia Jensen; Boye L Jensen; Brian Kloster; Morten Jønler; Lars Lund
Journal:  Pflugers Arch       Date:  2021-04-12       Impact factor: 3.657

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.